Evidence map›Paper›PMID 17505593›Full record

ArticleBrazilian journal of otorhinolaryngology

Optimizing the pharmacological component of integrated balance therapy.

Maurício Malavasi Ganança, Heloisa Helena Caovilla, Mário Sérgio Lei Munhoz, Cristina Freitas Ganança, Maria Leonor Garcia da Silva, Flavio Serafini, Fernando Freitas Ganança

Open access · goldAbstract read
In one paragraph

Article in Brazilian journal of otorhinolaryngology. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed
1.1field-weighted citation impact, top 18% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed, 18 citations in OpenAlex.

  1. Article
  2. Article
  3. Association of cinnarizine and betahistine in prophylactic therapy for Ménière's disease with and without migraine.Acta otorhinolaryngologica Italica : organo ufficiale della Societa italiana di otorinolaringologia e chirurgia cervico-facciale · 2014
    Review
  4. A Randomized Trial of Chinese Diaoshi Jifa on Treatment of Dizziness in Meniere's Disease.Evidence-based complementary and alternative medicine : eCAM · 2014
    Article
  5. Neuropharmacology of vestibular system disorders.Current neuropharmacology · 2010
    Article
  6. Article
  7. Review
  8. Article
  9. Review
  10. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 1 institution in 2 countries.

Maurício Malavasi GanançaFederal University of São Paulo, São Paulo, Brazil. mauricio.gananca@globo.com
Heloisa Helena Caovilla
Mário Sérgio Lei Munhoz
Cristina Freitas Ganança
Maria Leonor Garcia da Silva
Flavio Serafini
Fernando Freitas Ganança
Universidade Federal de São Paulo · BR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

unlabelledDrug treatment is an important option for the treatment of peripheral vestibular diseases.

aimTo identify the drug component associated with optimal integrated balance therapy (IBT) for Ménières disease or other peripheral vestibular disorders. MATERIALS AND

methodsAnalysis of a series of patients with Ménières disease patients or patients with other peripheral vestibular disorders that received IBT involving either no medication or betahistine, cinnarizine, clonazepam, flunarizine or Ginkgo biloba during 120 days.

resultsIn Ménières disease, significant differences were observed for all drug therapies (60 days) versus no medication; betahistine was significantly more effective than all other drugs at 60 and 120 days. For non-Ménières disorders, significant differences were observed among betahistine, cinnarizine, clonazepam and flunarizine and no medication after 60 days; all drug therapies were significantly more effective than no medication after 120 days; betahistine, cinnarizine or clonazepam were equally effective and betahistine was more effective than flunarizine and EGb 761. All treatment options were well tolerated.

conclusionsDrug therapies were more effective than no medication in the IBT for patients with Ménières disease or other peripheral vestibular disorders. Betahistine was the most effective medication for patients with Ménières disease and was as effective as cinnarizine and clonazepam for other peripheral vestibular disorders.

Indexed as

BetahistineCinnarizineClonazepamCombined Modality TherapyDrug Therapy, CombinationFemaleFlunarizineGinkgo bilobaGinkgo ExtractHistamine AgonistsHistamine H1 AntagonistsHumansMaleMeniere DiseaseMiddle AgedPlant ExtractsBetahistineCinnarizineClonazepamFlunarizineGinkgo biloba extractGinkgo ExtractHistamine AgonistsHistamine H1 AntagonistsPlant Extracts

Identifiers

PMID17505593
PMCPMC9443544
OpenAlexW2700241829

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.